Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 2
1977 6
1978 5
1979 19
1980 15
1981 26
1982 57
1983 68
1984 69
1985 82
1986 62
1987 72
1988 57
1989 46
1990 38
1991 32
1992 25
1993 31
1994 18
1995 25
1996 25
1997 30
1998 31
1999 25
2000 29
2001 39
2002 46
2003 64
2004 61
2005 66
2006 83
2007 100
2008 99
2009 102
2010 114
2011 119
2012 103
2013 121
2014 125
2015 159
2016 144
2017 149
2018 168
2019 170
2020 159
2021 177
2022 167
2023 115
2024 44

Text availability

Article attribute

Article type

Publication date

Search Results

3,249 results

Results by year

Filters applied: . Clear all
Page 1
Continuous subcutaneous insulin infusion versus multiple daily injection regimens in children and young people at diagnosis of type 1 diabetes: pragmatic randomised controlled trial and economic evaluation.
Blair JC, McKay A, Ridyard C, Thornborough K, Bedson E, Peak M, Didi M, Annan F, Gregory JW, Hughes DA, Gamble C; SCIPI investigators. Blair JC, et al. BMJ. 2019 Apr 3;365:l1226. doi: 10.1136/bmj.l1226. BMJ. 2019. PMID: 30944112 Free PMC article. Clinical Trial.
OBJECTIVE: To compare the efficacy, safety, and cost utility of continuous subcutaneous insulin infusion (CSII) with multiple daily injection (MDI) regimens during the first year following diagnosis of type 1 diabetes in children and young people. ...S …
OBJECTIVE: To compare the efficacy, safety, and cost utility of continuous subcutaneous insulin infusion (CSII) …
Continuous Subcutaneous Infusion Versus Multiple Daily Injections of Insulin for Pregestational Diabetes in Pregnancy: A Systematic Review and Meta-Analysis.
Fisher SA, Huang J, DuBord AY, Xu NY, Beestrum M, Niznik C, Yeung AM, Nguyen KT, Klonoff DC, Yee LM. Fisher SA, et al. J Diabetes Sci Technol. 2023 Sep;17(5):1337-1363. doi: 10.1177/19322968231186626. Epub 2023 Aug 4. J Diabetes Sci Technol. 2023. PMID: 37542367 Review.
BACKGROUND: The use of continuous subcutaneous insulin infusion (CSII) therapy in pregnancies affected by pregestational diabetes mellitus (DM) has generated mixed outcome data worthy of further investigation. ...METHODS: A predefined, systematic, libr …
BACKGROUND: The use of continuous subcutaneous insulin infusion (CSII) therapy in pregnancies affected by preges …
Continuous subcutaneous insulin infusion versus multiple daily injections for type 1 diabetes.
Ross LJ, Neville KA. Ross LJ, et al. J Paediatr Child Health. 2019 Jun;55(6):718-722. doi: 10.1111/jpc.14480. J Paediatr Child Health. 2019. PMID: 31155794 Review.
To review the literature on continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI) to help the family of a 13-year-old girl with type 1 diabetes mellitus on MDI choose the best insulin delivery method for her to impr …
To review the literature on continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI) …
Advancing continuous subcutaneous insulin infusion in vivo: New insights into tissue challenges.
Kesserwan S, Mulka A, Sharafieh R, Qiao Y, Wu R, Kreutzer DL, Klueh U. Kesserwan S, et al. J Biomed Mater Res A. 2021 Jul;109(7):1065-1079. doi: 10.1002/jbm.a.37097. Epub 2020 Sep 18. J Biomed Mater Res A. 2021. PMID: 32896081 Free PMC article.
Continuous Subcutaneous Insulin Infusion (CSII) is superior to conventional insulin therapy as it improves glycemic control thus reducing the probability of diabetic complications. ...At both 3- and 7-days post infusion, these were predom …
Continuous Subcutaneous Insulin Infusion (CSII) is superior to conventional insulin therapy as it improve …
Use of continuous subcutaneous insulin infusion (CSII) therapy in pediatric diabetes patients in the perioperative period.
Vanderhoek SM, Wolf RM. Vanderhoek SM, et al. Paediatr Anaesth. 2019 Sep;29(9):901-906. doi: 10.1111/pan.13708. Epub 2019 Aug 12. Paediatr Anaesth. 2019. PMID: 31325198 Review.
Diabetes mellitus is one of the most common endocrinopathies encountered in the perioperative period, and the pediatric population is increasingly using continuous subcutaneous insulin infusions for diabetes management. As these patients present for pr …
Diabetes mellitus is one of the most common endocrinopathies encountered in the perioperative period, and the pediatric population is increa …
Continuous subcutaneous insulin infusion (CSII) pumps.
Valla V. Valla V. Adv Exp Med Biol. 2012;771:414-9. doi: 10.1007/978-1-4614-5441-0_29. Adv Exp Med Biol. 2012. PMID: 23393693 Review.
Continuous Subcutaneous Insulin Infusion (CSII) is the first step to the development of the so-called "artificial pancreas" and is intended to restore blood glucose levels and the frequency of hypoglycemic episodes. ...The advantages of insulin …
Continuous Subcutaneous Insulin Infusion (CSII) is the first step to the development of the so-called "artificia …
Continuous subcutaneous insulin infusion therapy: A primer on insulin pumps.
Potti LG, Haines ST. Potti LG, et al. J Am Pharm Assoc (2003). 2009 Jan-Feb;49(1):e1-13; quiz e14-7. doi: 10.1331/JAphA.2009.08122. J Am Pharm Assoc (2003). 2009. PMID: 19196588 Review.
OBJECTIVE: To summarize the role, benefits, and risks of continuous subcutaneous insulin infusion (CSII) therapy for treating diabetes. DATA SOURCES: A literature search was conducted in Medline (1996 to July 2008) using the search terms intensive i …
OBJECTIVE: To summarize the role, benefits, and risks of continuous subcutaneous insulin infusion (CSII) therapy …
Continuous subcutaneous insulin infusion for managing diabetes: women's health implications.
Hood DG. Hood DG. Nurs Womens Health. 2012 Aug-Sep;16(4):308-18. doi: 10.1111/j.1751-486X.2012.01749.x. Nurs Womens Health. 2012. PMID: 22900807 Review.
The use of continuous subcutaneous insulin infusion (CSII), also called insulin pump therapy, is increasing for management of type 1 diabetes. This article provides a comprehensive background on CSII, reviews recent studies comparing it to multi …
The use of continuous subcutaneous insulin infusion (CSII), also called insulin pump therapy, is increasi …
Intrapartum continuous subcutaneous insulin infusion vs intravenous insulin infusion among pregnant individuals with type 1 diabetes mellitus: a randomized controlled trial.
Wilkie GL, Delpapa E, Leftwich HK. Wilkie GL, et al. Am J Obstet Gynecol. 2023 Dec;229(6):680.e1-680.e8. doi: 10.1016/j.ajog.2023.07.003. Epub 2023 Jul 8. Am J Obstet Gynecol. 2023. PMID: 37429432 Clinical Trial.
After written informed consent, participants were randomly allocated to 1 of 2 intrapartum insulin administration strategies: continuation of their continuous subcutaneous insulin infusion or intravenous insulin infusion. .. …
After written informed consent, participants were randomly allocated to 1 of 2 intrapartum insulin administration strategies: cont …
Consensus Statement on Use of Continuous Subcutaneous Insulin Infusion Therapy in the Hospital.
Thompson B, Korytkowski M, Klonoff DC, Cook CB. Thompson B, et al. J Diabetes Sci Technol. 2018 Jul;12(4):880-889. doi: 10.1177/1932296818769933. Epub 2018 Apr 21. J Diabetes Sci Technol. 2018. PMID: 29681173 Free PMC article.
In May 2017, the Diabetes Technology Society convened a panel of US experts on inpatient diabetes management to discuss the current and potential role of continuous subcutaneous insulin infusion (CSII) therapy in the hospital. ...Providers need to be c …
In May 2017, the Diabetes Technology Society convened a panel of US experts on inpatient diabetes management to discuss the current and pote …
3,249 results